139 related articles for article (PubMed ID: 31622561)
21. Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q₁₀ as naked nanocrystals.
Sun J; Wang F; Sui Y; She Z; Zhai W; Wang C; Deng Y
Int J Nanomedicine; 2012; 7():5733-44. PubMed ID: 23166438
[TBL] [Abstract][Full Text] [Related]
22. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X
Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058
[TBL] [Abstract][Full Text] [Related]
23. Physicochemical, Pharmacodynamic and Pharmacokinetic Characterization of Soluplus Stabilized Nanosuspension of Tacrolimus.
Varshosaz J; Minayian M; Yazdekhasti S
Curr Drug Deliv; 2017; 14(4):521-535. PubMed ID: 27697037
[TBL] [Abstract][Full Text] [Related]
24. Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo.
Tuomela A; Liu P; Puranen J; Rönkkö S; Laaksonen T; Kalesnykas G; Oksala O; Ilkka J; Laru J; Järvinen K; Hirvonen J; Peltonen L
Int J Pharm; 2014 Jun; 467(1-2):34-41. PubMed ID: 24680962
[TBL] [Abstract][Full Text] [Related]
25. Curcumin nanoparticles containing poloxamer or soluplus tailored by high pressure homogenization using antisolvent crystallization.
Homayouni A; Amini M; Sohrabi M; Varshosaz J; Nokhodchi A
Int J Pharm; 2019 May; 562():124-134. PubMed ID: 30898640
[TBL] [Abstract][Full Text] [Related]
26. Application of Soluplus to Improve the Flowability and Dissolution of Baicalein Phospholipid Complex.
Fan J; Dai Y; Shen H; Ju J; Zhao Z
Molecules; 2017 May; 22(5):. PubMed ID: 28492487
[TBL] [Abstract][Full Text] [Related]
27. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth.
Ghosh I; Bose S; Vippagunta R; Harmon F
Int J Pharm; 2011 May; 409(1-2):260-8. PubMed ID: 21371540
[TBL] [Abstract][Full Text] [Related]
28. Spironolactone nanocrystals for oral administration: Different pharmacokinetic performances induced by stabilizers.
Mu S; Li M; Guo M; Yang W; Wang Y; Li J; Fu Q; He Z
Colloids Surf B Biointerfaces; 2016 Nov; 147():73-80. PubMed ID: 27490456
[TBL] [Abstract][Full Text] [Related]
29. Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation.
Shah SM; Ullah F; Khan S; Shah SM; de Matas M; Hussain Z; Minhas MU; AbdEl-Salam NM; Assi KH; Isreb M
Drug Des Devel Ther; 2016; 10():3837-3850. PubMed ID: 27920499
[TBL] [Abstract][Full Text] [Related]
30. Pharmaceutical Strategies for Stabilizing Drug Nanocrystals.
Yang H; Kim H; Jung S; Seo H; Nida SK; Yoo SY; Lee J
Curr Pharm Des; 2018; 24(21):2362-2374. PubMed ID: 29766785
[TBL] [Abstract][Full Text] [Related]
31. Enhancing the Solubility of Fenofibrate by Nanocrystal Formation and Encapsulation.
Kumar R; Siril PF
AAPS PharmSciTech; 2018 Jan; 19(1):284-292. PubMed ID: 28702816
[TBL] [Abstract][Full Text] [Related]
32. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
[TBL] [Abstract][Full Text] [Related]
33. Formulation and characterization of biocompatible and stable I.V. itraconazole nanosuspensions stabilized by a new stabilizer polyethylene glycol-poly(β-Benzyl-l-aspartate) (PEG-PBLA).
Zong L; Li X; Wang H; Cao Y; Yin L; Li M; Wei Z; Chen D; Pu X; Han J
Int J Pharm; 2017 Oct; 531(1):108-117. PubMed ID: 28830781
[TBL] [Abstract][Full Text] [Related]
34. Preparation and Evaluation of Diosgenin Nanocrystals to Improve Oral Bioavailability.
Liu CZ; Chang JH; Zhang L; Xue HF; Liu XG; Liu P; Fu Q
AAPS PharmSciTech; 2017 Aug; 18(6):2067-2076. PubMed ID: 27995466
[TBL] [Abstract][Full Text] [Related]
35. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension.
Ahuja BK; Jena SK; Paidi SK; Bagri S; Suresh S
Int J Pharm; 2015 Jan; 478(2):540-52. PubMed ID: 25490182
[TBL] [Abstract][Full Text] [Related]
36. Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: III. Impact of drug nanoparticle loading.
Krull SM; Moreno J; Li M; Bilgili E; Davé RN
Int J Pharm; 2017 May; 523(1):33-41. PubMed ID: 28315716
[TBL] [Abstract][Full Text] [Related]
37. Dissolution and oral absorption of pranlukast nanosuspensions stabilized by hydroxypropylmethyl cellulose.
Baek IH; Kim JS; Ha ES; Choo GH; Cho W; Hwang SJ; Kim MS
Int J Biol Macromol; 2014 Jun; 67():53-7. PubMed ID: 24631786
[TBL] [Abstract][Full Text] [Related]
38. Improved solubility and oral bioavailability of apigenin via Soluplus/Pluronic F127 binary mixed micelles system.
Zhang Z; Cui C; Wei F; Lv H
Drug Dev Ind Pharm; 2017 Aug; 43(8):1276-1282. PubMed ID: 28358225
[TBL] [Abstract][Full Text] [Related]
39. Improved oral absorption of dutasteride via Soluplus®-based supersaturable self-emulsifying drug delivery system (S-SEDDS).
Lee DH; Yeom DW; Song YS; Cho HR; Choi YS; Kang MJ; Choi YW
Int J Pharm; 2015 Jan; 478(1):341-347. PubMed ID: 25437113
[TBL] [Abstract][Full Text] [Related]
40. Formulation, evaluation and optimization of the felodipine nanosuspension to be used for direct compression to tablet for in vitro dissolution enhancement.
Mori D; Makwana J; Parmar R; Patel K; Chavda J
Pak J Pharm Sci; 2016 Nov; 29(6):1927-1936. PubMed ID: 28375107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
